|
Variables
|
Total
|
Survival group
|
Nonsurvival group
|
P
|
|---|
|
EHSS establishment (n)
|
90
|
69
|
21
| |
|
Male [n(%)]
|
84 (93.3)
|
64 (92.8)
|
20 (95.2)
|
1.000
|
|
Age [year, M(Q)]
|
22 (19–32)
|
22 (19–26.5)
|
27 (20.5–37.5)
|
0.066
|
|
APACHE II score (x ± s)
|
23.5 ± 8.6
|
20.7 ± 7.4
|
32.8 ± 4.7
|
0.048
|
|
Vasoactive drugs [n(%)]
|
25 (27.8)
|
14 (20.3)
|
11 (52.4)
|
0.013
|
|
Cooling effect [n(%)]
|
32 (35.6)
|
27 (39.1)
|
5 (23.8)
|
0.161
|
|
EHSS verification (n)
|
80
|
62
|
18
| |
|
Male [n(%)]
|
72 (90.0)
|
58 (93.5)
|
14 (77.8)
|
0.071
|
|
Age [year, M(Q)]
|
24 (20–30)
|
25 (20.7–30.2)
|
20.5 (19.7–27.2)
|
0.146
|
|
APACHE II score (x ± s)
|
21.2 ± 7.3
|
18.9 ± 5.9
|
29.1 ± 6.4
|
< 0.001
|
|
Vasoactive drugs [n(%)]
|
29 (36.3)
|
17 (27.4)
|
12 (66.7)
|
0.002
|
|
Cooling effect [n(%)]
|
35 (43.8)
|
29 (46.8)
|
6 (33.3)
|
0.312
|
- EHSS Exertional Heat Stroke Score, APACHE II Acute Physiology and Chronic Health Evaluation II score, Cooling effect. Core body temperature dropped to 38.5 °C within 2 h after EHS onset
